Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05536076 · ClinicalTrials.gov registry record · NA
Effect of Hypercapnia Treatment on Respiratory Recovery After Spinal Cord Injury
A NA study of Sleep Apnea and Hypercapnia, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05536076: Recruiting NA study of Sleep Apnea and Hypercapnia, sponsored by VA Office of Research and Development.
NCT05536076 is a NA study of Sleep Apnea and Hypercapnia that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 30 participants, below the 2,988-participant average among 36 other Sleep Apnea trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05536076, a NA study of Sleep Apnea and Hypercapnia, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
It is estimated that 1,275,000 people in the United States alone live with spinal cord injury, including around 100,000 Veterans with spinal cord injury, making the V.A. the largest integrated health care system in the world for spinal cord injuries injury care. New therapies are needed to prevent the morbidities and mortalities associated with the high prevalence of respiratory disorders in Veterans with spinal cord injury. The current research project and future studies would set the base for developing innovative therapies for this disorder. This proposal addresses a new therapeutic intervention for sleep apnea in spinal cord injury. The investigators hypothesized that daily hypercapnia treatments improve respiratory symptoms and alleviate sleep apnea in patients with chronic spinal cord injury. The investigators will perform a pilot study to examine the impact of daily hypercapnia treatments for-two week durations among Veterans with spinal cord injury. The investigators believe that this novel approach to treating sleep apnea and will yield significant new knowledge that improves the health and quality of life of these patients.
Primary Outcome
Determine the recruitment rate in the intervention arm and determine how many continue into the sham arm. (Number of patients enrolled and completed the study)
Conditions Studied
Interventions
- OTHER Hypercapnia treatment
Study Locations (1)
Michigan
- John D. Dingell VA Medical Center, Detroit, MI - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What NCT05536076 shows while recruiting
NCT05536076 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,988-participant average among 36 other Sleep Apnea trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Hypercapnia treatment is the first listed.
NCT05536076 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05536076 about?
NCT05536076 is a clinical study titled "Effect of Hypercapnia Treatment on Respiratory Recovery After Spinal Cord Injury". It is estimated that 1,275,000 people in the United States alone live with spinal cord injury, including around 100,000 Veterans with spinal cord injury, making the V.A. the largest integrated health care system in the world for spinal cord injuries injury care. New therapies are needed to prevent t...
What is the current status of trial NCT05536076?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-03-01. Estimated completion is 2026-02-28.
What conditions does trial NCT05536076 study?
This clinical trial studies the following conditions: Sleep Apnea, Hypercapnia, SCI/D.
What interventions are being tested in trial NCT05536076?
The interventions under investigation include: Hypercapnia treatment (OTHER).
Who is sponsoring clinical trial NCT05536076?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05536076 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05536076's enrollment target sits among peer trials
30 30th of 36 higher than 7 of 36 other Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanisms of Prediabetic States in Sleep Apnea
RECRUITING · NA
-
Reaching for Equity in Sleep Apnea Treatment (REST) Study
RECRUITING · NA
-
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
RECRUITING · NA
-
Janus II Feasibility
RECRUITING · NA
-
Technology-Supported Treatment of Sleep Apnea in Prediabetes
ACTIVE NOT RECRUITING · NA
-
Sleep for Stroke Management and Recovery Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI